MAPT and Alzheimer disease: The aim of this study is to investigate the effect of the three peptides, i.e., KLVFF, RGKLVFFGR and RIIGL, on expressions of proteins related with β-amyloid and tau protein that causing AD in the differentiated SH-SY5Y cells induced by RA and BDNF.